| FSCPX | RYRAX | FSCPX / RYRAX | |
| Total Expense Ratio | 0.70 | 1.64 | 43% |
| Annual Report Gross Expense Ratio | 0.70 | 1.69 | 41% |
| Fund Existence | 35 years | 28 years | - |
| Gain YTD | -0.881 | 8.280 | -11% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | 500 | 1000 | 50% |
| Net Assets | 509M | 6.41M | 7,937% |
| Annual Yield % from dividends | 0.06 | 0.00 | - |
| Returns for 1 year | -4.90 | 6.06 | -81% |
| Returns for 3 years | 47.10 | 38.41 | 123% |
| Returns for 5 years | 5.86 | 12.60 | 47% |
| Returns for 10 years | 87.32 | 111.15 | 79% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| THNR | 26.22 | 0.24 | +0.92% |
| Amplify Weight Loss Drug & Treatment ETF | |||
| FSMD | 44.26 | 0.19 | +0.43% |
| Fidelity Small-Mid Multifactor ETF | |||
| QARP | 58.72 | 0.19 | +0.32% |
| Xtrackers Russell 1000 US QARP ETF | |||
| SPCZ | 28.71 | N/A | N/A |
| RiverNorth Ehd PMgr SPAC ETF | |||
| MCI | 20.99 | -0.02 | -0.10% |
| Barings Corporate Investors | |||